Tonix Pharmaceuticals Holding Corp.

09/25/2025 | Press release | Archived content

TNX-2900 for Prader-Willi Syndrome

Tonix Pharmaceuticals Holding Corp. published this content on September 25, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 29, 2025 at 11:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]